Page last updated: 2024-11-01

ondansetron and Aberrant Tissue

ondansetron has been researched along with Aberrant Tissue in 1 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Research Excerpts

ExcerptRelevanceReference
"The effects of seizures were observed to a much larger extent in malformed than in normal brain tissue."1.33Determinants of drug brain uptake in a rat model of seizure-associated malformations of cortical development. ( Bassanini, S; Battaglia, G; Caccia, S; Chimenti, S; Gagliardi, B; Guiso, G; Marchi, N; Noé, F; Ravizza, T; Rizzi, M; Vezzani, A, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Marchi, N1
Guiso, G1
Caccia, S1
Rizzi, M1
Gagliardi, B1
Noé, F1
Ravizza, T1
Bassanini, S1
Chimenti, S1
Battaglia, G1
Vezzani, A1

Other Studies

1 other study available for ondansetron and Aberrant Tissue

ArticleYear
Determinants of drug brain uptake in a rat model of seizure-associated malformations of cortical development.
    Neurobiology of disease, 2006, Volume: 24, Issue:3

    Topics: Animals; Anticonvulsants; Astrocytes; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood

2006